Audentes Therapeutics, Inc. (BOLD) Reaches $36.63 After 6.00% Down Move; 3 Analysts Bullish American Assets Trust, Inc. (AAT)

January 7, 2018 - By Maria Brooks

The stock of Audentes Therapeutics, Inc. (NASDAQ:BOLD) is a huge mover today! The stock decreased 10.26% or $4.185 during the last trading session, reaching $36.625. About 665,479 shares traded or 145.08% up from the average. Audentes Therapeutics, Inc. (NASDAQ:BOLD) has 0.00% since January 7, 2017 and is . It has underperformed by 16.70% the S&P500.The move comes after 8 months negative chart setup for the $1.09B company. It was reported on Jan, 7 by Barchart.com. We have $34.43 PT which if reached, will make NASDAQ:BOLD worth $65.58M less.

Among 6 analysts covering American Assets Trust (NYSE:AAT), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. American Assets Trust had 12 analyst reports since July 22, 2015 according to SRatingsIntel. Canaccord Genuity maintained the shares of AAT in report on Wednesday, April 12 with “Buy” rating. The firm has “Hold” rating by KeyBanc Capital Markets given on Friday, September 22. Mizuho upgraded American Assets Trust, Inc. (NYSE:AAT) on Monday, November 7 to “Buy” rating. RBC Capital Markets maintained American Assets Trust, Inc. (NYSE:AAT) on Thursday, June 8 with “Buy” rating. The firm has “Neutral” rating by Mizuho given on Monday, July 18. The firm earned “Hold” rating on Monday, October 23 by KeyBanc Capital Markets. Mizuho downgraded American Assets Trust, Inc. (NYSE:AAT) rating on Wednesday, February 22. Mizuho has “Neutral” rating and $44 target. As per Thursday, November 2, the company rating was downgraded by Bank of America. The rating was initiated by Canaccord Genuity with “Buy” on Wednesday, July 22. The firm has “Outperform” rating by RBC Capital Markets given on Monday, May 2. See American Assets Trust, Inc. (NYSE:AAT) latest ratings:

02/11/2017 Broker: Bank of America Rating: Hold New Target: $41.0 Downgrade
23/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
22/09/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
01/08/2017 Broker: Canaccord Genuity Rating: Buy New Target: $50.0000 Maintain

Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company has market cap of $1.09 billion. The firm is developing AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT982 for the treatment of pompe disease; and AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. It currently has negative earnings. Audentes Therapeutics, Inc. has a collaboration with the University of Pennsylvania for the treatment of Crigler-Najjar.

Analysts await Audentes Therapeutics, Inc. (NASDAQ:BOLD) to report earnings on March, 8. They expect $-0.93 EPS, down 2.20% or $0.02 from last year’s $-0.91 per share. After $-0.88 actual EPS reported by Audentes Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 5.68% negative EPS growth.

Investors sentiment decreased to 1.14 in Q3 2017. Its down 0.57, from 1.71 in 2017Q2. It dropped, as 18 investors sold American Assets Trust, Inc. shares while 47 reduced holdings. 18 funds opened positions while 56 raised stakes. 44.88 million shares or 1.13% less from 45.40 million shares in 2017Q2 were reported. Wellington Management Gp Ltd Liability Partnership has invested 0.01% in American Assets Trust, Inc. (NYSE:AAT). Bamco Incorporated Ny invested 0.11% in American Assets Trust, Inc. (NYSE:AAT). New Mexico Educational Retirement Board holds 0.01% of its portfolio in American Assets Trust, Inc. (NYSE:AAT) for 6,500 shares. Mason Street Advsr Lc reported 10,500 shares. Citadel Advisors Lc accumulated 61,954 shares or 0% of the stock. 85,166 are held by Ubs Asset Management Americas Inc. Tiaa Cref Invest Limited Liability Company holds 0.01% or 342,043 shares. Swiss National Bank & Trust owns 58,800 shares. Profund Advsrs Llc accumulated 0.01% or 5,332 shares. State Of Tennessee Treasury Department owns 34,601 shares or 0.01% of their US portfolio. Voya Investment Mngmt Limited Liability Corp holds 0% or 19,481 shares in its portfolio. Boston has invested 0.11% in American Assets Trust, Inc. (NYSE:AAT). Schroder Investment Management Group Incorporated invested in 0% or 5,080 shares. New York-based Alpine Woods Cap Invsts Limited Liability Company has invested 0.05% in American Assets Trust, Inc. (NYSE:AAT). Northern Trust has 904,960 shares.

Since August 7, 2017, it had 12 buys, and 1 sale for $14.18 million activity. Shares for $1.71M were bought by RADY ERNEST S on Monday, August 28. Gammieri Jerry sold 277 shares worth $11,268.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>